The Latest Breaking News from Epilepsy

EPILEPSY Scotland has launched a month-long campaign to increase awareness of epilepsy amongst students in colleges and universities across Scotland.

Biopharma company developing next-generation mental health treatments Bright Minds Biosciences Inc. (NASDAQ: DRUG) has closed its overnight offering for gross proceeds of approximately $4 million.

Kat Cooper says her daughter is deteriorating since she stopped her medicinal cannabis, which costs $196 per 1 millilitre every 12 days.

Paige Ellis' died after a suspected epileptic seizure

She is the second pregnant woman from the same town to die in similar circumstances

The US Food and Drug Administration (FDA) has accepted for filing Krystal Biotech’s (NASDAQ:KRYS) Biologics License Application (BLA) for its lead candidate B-VEC in the treatment of patients with dystrophic epidermolysis bullosa (DEB). The regulatory agency has granted  Priority Review designation and assigned a target actin date of February 17,…

Callum suffered serious injury as a toddler which left him blind and deaf, while he was also diagnosed with quadriplegia cerebral palsy and epilepsy.

Avicanna (OTCQX: AVCNF), a biopharmaceutical company focused on cannabinoid-based products, released its Q2 2022 highlights:

A child diagnosed with a rare form of epilepsy which causes her to have multiple seizures a day is to undergo life-saving surgery to detach part of her brain.

Thea Steele was diagnosed with a rare form of epilepsy which can cause 'catastrophic' damage

Kodiak Sciences Inc. (NASDAQ:KOD) announced positive topline results its BEACON Phase 3 study of tarcocimab tedromer (KSI-301; tarcocimab) in patients with macular edema due to retinal vein occlusion. Kodiak shares traded in a range of $10.02 to $11.79 on a day volume of 4.05 million shares, closed regular trading session…